Screening for viral markers in volunteer and replacement blood donors in West Africa

Vox Sang. 2001 Apr;80(3):142-7. doi: 10.1046/j.1423-0410.2001.00023.x.

Abstract

Background and objectives: West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.

Materials and methods: Replacement and volunteer blood donors were screened using enzyme immunoassays (EIAs) for hepatitis B surface antigen (HBsAg), human immunodeficiency virus antibodies (anti-HIV), HIV p24 antigen, human T-cell lymphocytotrophic virus-I and -II antibodies (anti-HTLV-I/II) and hepatitis C virus antibodies (anti-HCV).

Results: HBsAg was present at an equally high frequency (15%) in young volunteer (median age 18 years) and older replacement (median age 33 years) blood donors. In contrast, the prevalence of anti-HIV and anti-HCV was significantly higher in replacement blood donors (2.4 and 0.3%, respectively, P < 0.001). HCV RNA was detected in 74 or 55% of seropositive donors, depending on the confirmatory criteria used. No p24 antigen-positive/anti-HIV-negative donations were found. The prevalence of HTLV-I/II was generally low (0.5%).

Conclusion: All blood donations should be screened for hepatitis B virus (HBV), HIV and HCV markers.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Antigens, Viral / blood*
  • Blood Donors*
  • Enzyme-Linked Immunosorbent Assay
  • Family
  • Female
  • Ghana / epidemiology
  • HIV Antibodies / blood
  • HIV Core Protein p24 / blood
  • HIV Seroprevalence
  • HTLV-I Antibodies / blood
  • HTLV-II Antibodies / blood
  • Hepatitis B Surface Antigens / blood
  • Hepatitis C Antibodies / blood
  • Humans
  • Male
  • Mass Screening*
  • Middle Aged
  • RNA, Viral / blood
  • Seroepidemiologic Studies
  • Transfusion Reaction
  • Viremia / blood
  • Viremia / diagnosis*
  • Viremia / epidemiology
  • Viremia / prevention & control
  • Viremia / transmission
  • Volunteers

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • HIV Antibodies
  • HIV Core Protein p24
  • HTLV-I Antibodies
  • HTLV-II Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies
  • RNA, Viral